eWellness Healthcare (EWLL) S-1 27 May 15 IPO registration Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015
Document And Entity Information
Entity Registrant Name	eWELLNESS HEALTHCARE Corp
Entity Central Index Key	1550020
Document Type	S-1
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Entity Filer Category	Smaller Reporting Accelerated Filer
Current Fiscal Year End Date	-19

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS
Cash	$25,753	$900
Advances - related party		7,054
Prepaid Expenses	71,845	26,274	4,770
Total current assets	97,598	34,228	4,770
Property & equipment, net	7,226	3,231	4,074
Intangible assets, net	22,077	22,816
TOTAL ASSETS	126,901	60,275	8,844
CURRENT LIABILITIES
Accounts payable and accrued expenses	139,162	174,044
Accounts payable and accrued expenses - related party	43,056	56,155
Accrued expenses - related party	25,076	30,181
Accrued compensation	414,000	329,000
Contingent liability	90,000	90,000
Short term note and liabilities	166,100
Total current liabilities	877,394	679,380
Convertible debt, net of discount	187,159	178,433
Total Liabilities	1,064,553	857,813
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, authorized, 10,000,000 shares, $.001 value, 0 shares issued and outstanding
Common stock, authorized 100,000,000 shares, $.001 par value, 16,881,000, 16,421,000 and 9,200,000 issued and outstanding, respectively	16,881	16,421	9,200
Share to be issued
Additional Paid in Capital	1,263,625	1,087,320	561,338
Accumulated deficit	-2,218,158	-1,901,279	-561,694
Total Stockholder's Equity (Deficit)	-937,652	-797,538	8,844
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$126,901	$60,275	$8,844

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000	10,000,000
Preferred stock, par value	$0.00	$0.00	$0.00
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, par value	$0.00	$0.00	$0.00
Common stock, shares issued	16,881,000	16,421,000	9,200,000
Common stock, shares outstanding	16,881,000	16,421,000	9,200,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Total Revenue
OPERATING EXPENSES
Executive compensation	186,000	186,000	744,000	423,000
General and administrative	34,588	25,031	231,124	40,930
Professional fees	90,394	29,671	259,856
Contingent liability expense			90,000
Research and development - related party		30	30	2,706
Total Operating Expenses	310,982	240,732	1,325,010	466,636
Loss from Operations	-310,982	-240,732	-1,325,010	-466,636
OTHER INCOME (EXPENSE)
Gain on extinguishment of debt	11,323		1,200
Interest income			7
Interest expense, related parties	-1,078		-2,708
Interest expense	-16,142		-13,074
Loss before Income Taxes	-316,879	-240,732	-1,339,585	-466,636
Income tax expense		-50
Net Loss	($316,879)	($240,782)	($1,339,585)	($466,636)
Basic and diluted (loss) per share	($0.02)	($0.03)	($0.10)	($0.05)
Basic and diluted weighted average shares outstanding	16,740,778	9,200,000	13,698,896	9,200,000

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (Deficit) (USD $)	Preferred Shares [Member]	Common Shares [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2012			$95,058	($95,058)
Balance, shares at Dec. 31, 2012
Common stock issued at incorporation		9,200	-200		9,000
Common stock issued at incorporation, shares		9,200,000
Contributed services			414,000		414,000
Expenses paid and assets contributed by shareholders			52,480		52,480
Shares issued for services @ $.10/share
Net loss				-466,636	-466,636
Balance at Dec. 31, 2013		9,200	561,338	-561,694	8,844
Balance, shares at Dec. 31, 2013		9,200,000
Imputed Interest			2,708		2,708
Contributed services			390,000		390,000
Recapitalization at merger		6,000	-22,509		-16,509
Recapitalization at merger, shares		6,000,000
Shares issued for services @ $.10/share		1,221	120,879		-122,100
Shares issued for services @ $.10/share, shares		1,221,000
Convertible debt discount			34,904		34,904
Net loss				-1,339,585	-1,339,585
Balance at Dec. 31, 2014		$16,421	$1,087,320	($1,901,279)	($797,538)
Balance, shares at Dec. 31, 2014		16,421,000

Consolidated_Statement_of_Stoc1

Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) (USD $)	Dec. 31, 2014
Statement of Stockholders' Equity [Abstract]
Shares issued for services price per share	$0.10

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities
Net loss	($316,879)	($240,782)	($1,339,585)	($466,636)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	950	449	2,797	140
Contributed services	97,500	1,500	390,000	423,000
Expenses paid by shareholders				43,496
Shares issued for services	9,389		122,100
Warrants issued for services	7,153
Convertible debt discount	8,726		34,904
Imputed interest - related party	1,078		2,708
Changes in operating assets and liabilities
Advances - related parties	7,054	-2,390	-7,054
Prepaid expense	16,074		-26,274
Accounts payable and accrued expenses	-34,880	22,661	67,535
Accounts payable - related party	-13,100		56,155
Accrued expenses - related party	-5,105	18,506	30,181
Contingent liability			90,000
Accrued compensation	85,000	186,000	329,000
Net cash used in operating activities	-137,040	-14,006	-247,533
Cash flows from investing activities
Intangible asset purchase			-20,000
Cash acquired in merger			90,000
Purchase of equipment	-4,207
Net cash used in investing activities	-4,207		70,000
Cash flows from financing activities
Common stock subscribed	146,100
Convertible loan payable	20,000	30,000	178,433
Net cash provided by financing activities	166,100	30,000	178,433
Net increase (decrease) in cash	24,853	15,994	900
Cash, beginning of period	900
Cash, end of period	25,753	15,994	900
Cash paid for:
Taxes		50
Interest Expense
Non-cash Investing and Financing Activities
Assets contributed by shareholders				8,844
Prepaid expense transferred to intangible assets			$4,770

The_Company

The Company	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
The Company	Note 1. The Company	Note 1. The Company
	The Company and Nature of Business	The Company and Nature of Business
	eWellness Healthcare Corporation (f/k/a Dignyte, Inc.), (the “Company”, “we”, “us”, “our”) was incorporated in the State of Nevada on April 7, 2011, to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. The Company has generated no revenues to date. Prior to the Share Exchange Agreement discussed below, other than issuing shares to its original shareholder, the Company never commenced any operational activities.	eWellness Healthcare Corporation (f/k/a Dignyte, Inc.), (the “Company”, “we”, “us”, “our”) was incorporated in the State of Nevada on April 7, 2011, to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. The Company has generated no revenues to date. Prior to the Share Exchange Agreement discussed below, other than issuing shares to its original shareholder, the Company never commenced any operational activities.
	eWellness was incorporated in Nevada in May 2013. Following a share exchange detailed below we completed in April 2014, pursuant to which eWellness Corporation, a Nevada corporation became our wholly owned subsidiary, we abandoned our prior business plan and we are now pursuing eWellness Corporation’s historical businesses and proposed businesses. Our historical business and operations will continue independently. eWellness is an early-stage Los Angeles based corporation that seeks to provide a unique telemedicine platform that offers Distance Monitored Physical Therapy (DMpt) Programs utilizing its proprietary WWW.PHZIO.COM telemedicine platform initially to pre-diabetic, cardiac and health challenged patients, through contracted physician practices and healthcare systems, in addition to in-office sessions. Based on today’s insurance landscape, our main revenue source shall come from a combination of in-office and telemedicine visits. Amid ongoing challenges and changes within the healthcare industry, telemedicine is emerging as an increasingly attractive tool for delivering quality medical services.	eWellness was incorporated in Nevada in May 2013. Following a share exchange detailed below we completed in April 2014, pursuant to which eWellness Corporation, a Nevada corporation became our wholly owned subsidiary, we abandoned our prior business plan and we are now pursuing eWellness Corporation’s historical businesses and proposed businesses. Our historical business and operations will continue independently. eWellness is an early-stage Los Angeles based corporation that seeks to provide a unique telemedicine platform that offers Distance Monitored Physical Therapy (DMpt) Programs utilizing its proprietary WWW.PHZIO.COM telemedicine platform initially to pre-diabetic, cardiac and health challenged patients, through contracted physician practices and healthcare systems, in addition to in-office sessions. Based on today’s insurance landscape, our main revenue source shall come from a combination of in-office and telemedicine visits. Amid ongoing challenges and changes within the healthcare industry, telemedicine is emerging as an increasingly attractive tool for delivering quality medical services.
	Share Exchange Agreement	Share Exchange Agreement
	On April 11, 2014, Digntye, Inc. (“Dignyte”), a publicly held Nevada corporation and eWellness Corporation (“Private Co”), a privately held company incorporated in Nevada, executed a Share Exchange Agreement (or “Initial Exchange Agreement”). Prior to the execution and delivery of the final Amended and Restated Share Exchange Agreement (the “Agreement”), the Board of Directors of Dignyte approved the Agreement and the transactions contemplated thereby. Similarly, the Board of Directors of the Private Co. approved the exchange. On April 25, 2014, immediately prior to the execution and delivery of the Agreement, Dignyte amended its certificate of incorporation to change its corporate name from “Dignyte, Inc.” to “eWellness Healthcare Corporation.”	On April 11, 2014, Digntye, Inc. (“Dignyte”), a publicly held Nevada corporation and eWellness Corporation (“Private Co”), a privately held company incorporated in Nevada, executed a Share Exchange Agreement (or “Initial Exchange Agreement”). Prior to the execution and delivery of the final Amended and Restated Share Exchange Agreement (the “Agreement”), the Board of Directors of Dignyte approved the Agreement and the transactions contemplated thereby. Similarly, the Board of Directors of the Private Co. approved the exchange. On April 25, 2014, immediately prior to the execution and delivery of the Agreement, Dignyte amended its certificate of incorporation to change its corporate name from “Dignyte, Inc.” to “eWellness Healthcare Corporation.”
	Pursuant to the Agreement, eWellness Healthcare Corporation issued 9,200,000 shares of unregistered common stock, $.001 par value (the “common stock”) to the shareholders of the Private Co. in exchange for all outstanding shares of the Private Co.’s common stock. In addition, our former chief executive officer agreed: (i) to tender 5,000,000 shares of common stock back to the Company for cancellation; (ii) assign from his holdings, an additional 2,500,000 shares to the shareholders of the Private Co. resulting in a total of 11,700,000 shares owned by those shareholders; and, (iii) to a further assignment of an additional 2,100,000 shares to other parties as stated therein (collectively, the “CEO Stock Actions”).	Pursuant to the Agreement, eWellness Healthcare Corporation issued 9,200,000 shares of unregistered common stock, $.001 par value (the “common stock”) to the shareholders of the Private Co. in exchange for all outstanding shares of the Private Co.’s common stock. In addition, our former chief executive officer agreed: (i) to tender 5,000,000 shares of common stock back to the Company for cancellation; (ii) assign from his holdings, an additional 2,500,000 shares to the shareholders of the Private Co. resulting in a total of 11,700,000 shares owned by those shareholders; and, (iii) to a further assignment of an additional 2,100,000 shares to other parties as stated therein (collectively, the “CEO Stock Actions”).
	As the parties satisfied all of the closing conditions, on April 30, 2014, we closed the Share Exchange. As a result, the Private Co. shareholders own approximately 76.97% of our issued and outstanding common stock, after giving effect to CEO Stock Actions.	As the parties satisfied all of the closing conditions, on April 30, 2014, we closed the Share Exchange. As a result, the Private Co. shareholders own approximately 76.97% of our issued and outstanding common stock, after giving effect to CEO Stock Actions.
	Following the Share Exchange, we abandoned our prior business plan and we are now pursuing the Private Co.’s historical businesses and proposed businesses. The Private Co. is the surviving company under the share exchange and became a wholly owned subsidiary of the Company.	Following the Share Exchange, we abandoned our prior business plan and we are now pursuing the Private Co.’s historical businesses and proposed businesses. The Private Co. is the surviving company under the share exchange and became a wholly owned subsidiary of the Company.
	For financial reporting purposes, the Share Exchange represents a “reverse merger” rather than a business combination. Consequently, the transaction is accounted for as a reverse-merger and recapitalization. eWellness Corporation is the acquirer for financial reporting purposes and Dignyte, Inc. is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the transactions are those of eWellness Corporation and are recorded at the historical cost basis of eWellness Corporation, and the consolidated financial statements after completion of the transaction include the assets, liabilities and operations of eWellness Healthcare Corporation, and eWellness Corporation from the closing date of the transaction. Additionally all historical equity accounts and awards of eWellness Corporation, including par value per share, share and per share numbers, have been adjusted to reflect the number of shares received in the transaction.	For financial reporting purposes, the Share Exchange represents a “reverse merger” rather than a business combination and eWellness is deemed to be the accounting acquirer in the transaction. The Share Exchange is being accounted for as a reverse-merger and recapitalization. eWellness is the acquirer for financial reporting purposes and the Company (eWellness Healthcare Corporation, formerly known as Dignyte, Inc.) is the acquired company. Consequently, the assets and liabilities and the operations that will be reflected in the historical financial statements prior to the Share Exchange will be those of eWellness and will be recorded at the historical cost basis of eWellness, and the consolidated financial statements after completion of the Share Exchange will include the assets and liabilities of the Company and eWellness, and the historical operations of eWellness and operations of the Combined Company from the closing date of the Share Exchange.
	The foregoing description of the Share Exchange Agreement does not purport to be complete and is qualified in its entirety by the Share Exchange Agreement, a copy of which is attached as Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the Securities and Exchange Commission on May 10, 2014. At the execution of the Share Exchange Agreement, the total number of shares of common stock outstanding was 15,200,000.
	The Company is in the initial phase of developing a unique telemedicine platform that offers Distance Monitored Physical Therapy Programs (“DMpt”) to pre-diabetic, cardiac and health challenged patients, through contracted physician practices and healthcare systems specifically designed to help prevent patients that are pre-diabetic from becoming diabetic. The Company’s activities are subject to significant risks and uncertainties, including failure to secure funding to operationalize the Company’s business plan.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies
	Basis of Presentation	Basis of Presentation
	The interim financial information of the Company as of periods ended March 31, 2015 and March 31, 2014 is unaudited. The balance sheet as of December 31, 2014 is derived from audited financial statements of eWellness Healthcare Corporation. The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial statements. Accordingly, they omit or condense footnotes and certain other information normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles. The accounting policies followed for quarterly financial reporting conform to the accounting policies disclosed in ASU 2014-10. In the opinion of management, all adjustments which are necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that can be expected for the entire year ending December 31, 2015. The unaudited financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2014.	These financial statements have been prepared to reflect the financial position, results of operations and cash flows of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
	Use of Estimates	Principles of Consolidation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these good faith estimates and judgments.	The accompanying consolidated financial statements include the accounts of eWellness Healthcare Corporation and its wholly owned subsidiary eWellness Corporation. All significant inter-company balances and transactions have been eliminated in consolidation.
	Going Concern	Financial Statement Reclassification
	For the period ended March 31, 2015, the Company has no revenues and no operations. The Company has an accumulated loss of $2,211,005. In view of these matters, there is substantive doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue operations is dependent upon the Company’s ability to raise additional capital and to ultimately achieve sustainable revenues and profitable operations, of which there can be no guarantee. The Company intends to finance its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.	Certain account balances from prior periods have been reclassified in these audited consolidated financial statements so as to conform to current period classifications.
	Deferred Offering and Acquisition Costs	Loss Per Share
	The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs will be charged against the capital raised. Should the offering be terminated, the deferred offering costs will be charged to operations during the period in which the offering is terminated. Direct acquisition costs will be expensed as incurred.	Basic loss per common share (“EPS”) is calculated by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted EPS is calculated by dividing net income (loss) by the weighted average number of common shares outstanding, plus the assumed exercise of all dilutive securities using the treasury stock or “as converted” method, as appropriate. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive.
	Fair Value of Financial Instruments	Use of Estimates
	The Company complies with the accounting guidance under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820-10, Fair Value Measurements, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these good faith estimates and judgments.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:	Cash and Cash Equivalents
	Level 1 – quoted market prices in active markets for identical assets or liabilities.	The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.
	Level 2 – inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.	Property and Equipment
	Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.	Property and equipment are recorded at historical cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is recorded over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant property and equipment categories are as follows:
	As of March 31, 2015 and 2014, the Company did not have Level 1, 2, or 3 financial assets or liabilities.	Furniture and Fixtures	5 - 7 Years
		Computer Equipment	5 - 7 Years
	Cash and Cash Equivalents	Software	3 Years
	Cash and cash equivalents includes all cash deposits and highly liquid financial instruments with an original maturity to the Company of three months or less.	The Company regularly evaluates whether events or circumstances have occurred that indicate the carrying value of long-lived assets may not be recoverable. If factors indicate the asset may not be recoverable, we compare the related undiscounted future net cash flows to the carrying value of the asset to determine if impairment exists. If the expected future net cash flows are less than the carrying value, an impairment charge is recognized based on the fair value of the asset. For the years ended December 31, 2014 and 2013, there was no impairment recognized.
	Property and Equipment	Intangible Assets
	Property and equipment consists of assets with useful lives longer than one year. Useful lives for assets have been determined to be 5 years for the Company.	The Company accounts for assets that are not physical in nature as intangible assets. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. Intangible assets with indefinite useful lives are reassessed each year for impairment. If an impairment has occurred, then a loss is recognized. An impairment loss is determined by subtracting the asset’s fair value from the asset’s book/carrying value.
	Revenue Recognition	Income Taxes
	The Company has yet to realize revenues from operations. Once the Company has commenced operations, it will recognize revenues when delivery of goods or completion of services has occurred provided there is persuasive evidence of an agreement, acceptance has been approved by its customers, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable.	The Company accounts for income taxes under FASB ASC 740-10-30. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accounting standards require the consideration of a valuation allowance for deferred tax assets if it is “more likely than not” that some component or all of the benefits of deferred tax assets will not be realized.
	Loss per Common Share	Recent Pronouncements
	The Company follows ASC Topic 260 to account for the loss per share. Basic loss per common share calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share calculations are determined by dividing net loss by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. As the Company has no common stock equivalents and has incurred losses for the period ended March 31, 2015, no dilutive shares are added into the loss per share calculations.	Adoption of ASU 2014-10 Development Stage Entities
	Recent Accounting Pronouncements	In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein.
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements presentation.	The Company adopted this standard effective June 30, 2014. The Company’s financial statements have been impacted by the adoption of this ASU mainly by the removal of inception-to-date information in the Company’s statements of operations, cash flows, and stockholders’ equity.
		From time to time, new accounting pronouncements are issued by FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption.
		Fair Value of Financial Instruments
		The Company’s financial instruments consist of cash and accounts payable. The carrying amount of cash and accounts payable approximates fair value because of the short-term nature of these items.

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern
Going Concern	Note 3. Going Concern
	For the year ended December 31, 2014, the Company has no revenues and no operations and had not emerged from the development stage. The Company has an accumulated loss of $1,901,279. In view of these matters, there is substantive doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue operations is dependent upon the Company’s ability to raise additional capital and to ultimately achieve sustainable revenues and profitable operations, of which there can be no guarantee. The Company intends to finance its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Property_and_Equipment

Property and Equipment	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3. Property and Equipment	Note 4. Property and Equipment
	Property and equipment consists of computer equipment that is stated at cost of $8,420 and $4,214 less accumulated depreciation of $1,194 and $983 at March 31, 2015 and December 31, 2014, respectively. Depreciation expense was $211 for the periods ended March 31, 2015 and March 31, 2014. Depreciation expense is computed using the straight-line method over the estimated useful life of the assets, which is five years for computer equipment.	Property and equipment consists of computer equipment at a stated cost of $4,214 and $4,214 less accumulated depreciation of $983 and $140 for the periods ended December 31, 2014 and 2013, respectively. Depreciation expense was $843 and $140 for the periods ended December 31, 2014 and 2013, respectively.

Intangible_Assets

Intangible Assets	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4. Intangible Assets	Note 5. Intangible Assets
	The Company recognizes the cost of a software license and a license for use of a programming code as intangible assets. The stated cost of these assets were $24,770 and $24,770 less accumulated amortization of $2,693 and $1,954 for the periods ended March 31, 2015 and December 31, 2014, respectively. For the periods ended March 31, 2015 and March 31, 2014, the amortization expense recorded was $739 and $239, respectively.	The Company recognized the cost of a software license and a license for use of a programming code as intangible assets. The stated cost of these assets were $24,770 and $0 less accumulated amortization of $1,954 and $0 for the years ended December 31, 2014 and 2013, respectively.

Related_Party_Transactions

Related Party Transactions	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Note 5. Related Party Transactions	Note 7. Related Party Transactions
	A company for which the Company’s former Secretary-Treasurer and CFO is also serving as CFO, has paid $73,610 on the Company’s behalf. The amount outstanding as of March 31, 2015 and December 31, 2014 was $43,056 and $56,155, respectively. During the periods ended March 31, 2015 and March31, 2014, the Company recorded $1,078 and $856, respectively of imputed interest on the amount owed to the related party based on an interest rate of 8%.	Through the year ended December 31, 2014, a related party, a company in which the former Secretary-Treasurer and CFO of the Company is also serving as CFO, has paid $67,710 on behalf of the Company. The amounts outstanding as of December 31, 2014 and December 31, 2013 were $56,155 and $0, respectively. During the year ended December 31, 2014, the Company recorded $2,708 imputed interest on the amount owed to the related party based on an interest rate of 8%.
	During 2014, the Company entered into a license agreement with a programming company in which one of our directors is Chief Marketing Officer. Through the licensing agreement, we obtained a perpetual license to use the programming code created by a video management platform as a base to develop our telemedicine video service for a license fee of $20,000. The license fee is recorded as an Intangible Asset and Accounts Payable on the Balance Sheet.	During the period ending December 31, 2014, the Company entered into a license agreement with a programming company in which one of our directors is Chief Marketing Officer. Through the licensing agreement, we obtained a perpetual license to use the programming code created by a video management platform as a base to develop our telemedicine video service for a license fee of $20,000. The license fee is recorded as an Intangible Asset and Accounts Payable on the Balance Sheet.
	The Company rents its Culver City, CA office space from a company owned by our CEO. The imputed rent expense of $500 per month is recorded in the Consolidated Statement of Operations and Additional Paid in Capital in the Balance Sheet.	The Company rents its Culver City, CA office space from a company owned by our CEO. The imputed rent expense of $500 per month is recorded in the Consolidated Statement of Operations and Additional Paid in Capital in the Balance Sheet.
	The officers of the Company incur personal expenses on behalf of the Company. The amounts outstanding as of March 31, 2015 and December 31, 2014 were $25,076 and $30,181, respectively.	Through the year ended December 31, 2014, the officers of the Company incur personal expenses on behalf of the Company. The amounts outstanding as of December 31, 2014 and December 31, 2013 were $30,181 and $0 respectively. In addition, advances were made to officers. The amounts due from officers as of December 31, 2014 and December 31, 2013 were $7,054 and $0, respectively.
		The Company periodically incurs expenses for research and development with a related party. At the periods ending December 31, 2014 and December 31, 2013, the Company had recorded expenses of $30 and $2,706, respectively.

Income_Taxes

Income Taxes	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Note 6. Income Taxes	Note 6. Income Taxes
	The tax provision for interim periods is determined using an estimate of the Company’s effective tax rate for the full year adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter the Company updates its estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company makes a cumulative adjustment.	Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	At March 31, 2015 and December 31, 2014, the Company has a full valuation allowance against its deferred tax assets, net of expected reversals of existing deferred tax liabilities, as it believes it is more likely than not that these benefits will not be realized.	Net deferred tax liabilities consist of the following components as of December 31, 2014 and 2013:
	The Company did not identify any material uncertain tax positions of the Company on returns that have been filed or that will be filed. The Company has not had operations and has deferred items consisting entirely of unused Net Operating Losses.. Since it is not thought that this Net Operating Loss will ever produce a tax benefit, even if examined by taxing authorities and disallowed entirely, there would be no effect on the financial statements.		2014			2013
	The Company’s policy is to recognize potential interest and penalties accrued related to unrecognized tax benefits within income tax expense. For the periods ended March 31 2015, and March 31, 2014 the Company did not recognize nor accrue any interest or penalties.	Deferred tax assets:
		NOL Carryover	$	314,000		$	15,067
		Deferred Rent		2,300			-
		Accrued Payroll		115,200			-
		Contingent Liability		31,500			-
		Deferred tax liabilities
		Depreciation		(300	)		-
		Valuation allowance		(462,700	)		(15,067	)
		Net deferred tax asset	$	-		$	-
		The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2014 and 2013 due to the following:
			2014			2013
		Book Income	$	(468,900	)	$	(158,656	)
		Depreciation		(300	)		-
		Contributed Services					143,820
		Non-Deductible Expenses		-			709
		Meals & Entertainment		2,500			-
		Stock for Expense Accounts		21,000			-
		Contributed Interest Expense		900			-
		Gain/Loss on settlement of debt through equity		(400	)		-
		Deferred Rent		-			-
		Accrued Payroll		115,200			-
		Related Party Interest		-			-
		Contingent Liability		31,500			-
		Valuation allowance		298,500			14,127
			$	-		$	-
		At December 31, 2014, the Company had net operating loss carryforwards of approximately $897,000 that may be offset against future taxable income from the year 2015 through 2034. No tax benefit has been reported in the December 31, 2014 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.
		Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carryforwards may be limited as to use in future years.
		The Company’s policy is to recognize potential interest and penalties accrued related to unrecognized tax benefits within income tax expense. For the years ended December 31, 2014 and 2013, the Company did not recognize any interest or penalties, nor did we have any interest or penalties accrued as of December 31, 2014 and 2013 related to unrecognized benefits.
		The Company has filed for an extension of the federal income tax return in the U.S for the year ended December 31, 2014. The tax years ended December 31, 2014, 2013, and 2012 are open for examination for federal income tax purposes and by other major taxing jurisdictions to which we are subject.

Convertible_Notes_Payable

Convertible Notes Payable	3 Months Ended					12 Months Ended
	Mar. 31, 2015					Dec. 31, 2014
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 7. Convertible Notes Payable					Note 8. Convertible Notes
	On December 23, 2014 the Company issued $213,337 convertible promissory notes (the “Notes”) and warrants to purchase shares of common stock to four individual investors. The overall terms of the Notes are as follows:					On December 23, 2014 the Company issued $213,337 convertible promissory notes (the “Notes”) and warrants to purchase shares of common stock to four individual investors. The overall terms of the Notes are as follows:
		●	Interest rate: 12% per annum. During the period ended March 31, 2015, the Company recorded $6,969 of accrued interest.				●	Interest rate: 12% per annum.
		●	Due date: One year after the registration statement registering the shares of common stock underlying the Notes for resale is declared effective. The Company is to pay the principal amount and all accrued and unpaid interest on or before the due date.				●	Due date: December 31, 2015. The Company is to pay the principal amount and all accrued and unpaid interest on or before the due date.
		●	Redemption right: Any time the closing price of the Company’s common stock has been at or above $1.50 for 20 consecutive trading days, the Company has the right to redeem all or any part of the principal and accrued interest of the Notes, following written notice to the holders of the Notes.				●	Redemption right: Any time the closing price of the Company’s common stock has been at or above $1.50 for 20 consecutive trading days, the Company has the right to redeem all or any part of the principal and accrued interest of the Notes, following written notice to the holders of the Notes.
		●	Optional Conversion: At the option of the holders, the Notes may be converted into shares of the Company’s common stock at a conversion price equal to $0.35 per share.				●	Optional Conversion: At the option of the holders, the Notes may be converted into shares of the Company’s common stock at a conversion price equal to $0.35 per share.
		●	Additionally, if the Company elects to exercise the redemption right, the holders have the opportunity to elect to take the cash payment or to convert all or any portion of the Notes into shares of the Company’s common stock.				●	Additionally, if the Company elects to exercise the redemption right, the holders have the opportunity to elect to take the cash payment or to convert all or any portion of the Notes into shares of the Company’s common stock.
		●	The conversion price is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events.				●	The conversion price is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events.
		●	The Notes are senior in rank to any other debt held by our officers, directors or affiliates and may not be subordinated to any other debt issued by us without the written consent of the holder.				●	The Notes are senior in rank to any other debt held by our officers, directors or affiliates and may not be subordinated to any other debt issued by us without the written consent of the holder.
		●	Warrants: The holders of the Notes are granted the right for three years to purchase 609,534 additional shares of common stock at $.35 per share.				●	Warrants: The holders of the Notes are granted the right through December 31, 2015 to purchase 609,534 additional shares of common stock at $.35 per share.
		●	During the time that any portion of these Notes are outstanding, if any Event of Default occurs and such Default is not cured by the Company within sixty (60) days of the occurrence of the Event of Default (the “Cure Period”), the amount equal to one hundred fifty percent (150%) of the outstanding principal amount of this Note, together with accrued interest and other amounts owing shall become at the holder’s election, immediately due and payable in cash. The holders at its option have the right, with three (3) business days advance written notice to the Company after the expiration of the Cure Period, to elect to convert the Notes into shares of the Company’s common stock pursuant to the Optional Conversion rights disclosed above.				●	During the time that any portion of these Notes are outstanding, if any Event of Default occurs and such Default is not cured by the Company within sixty (60) days of the occurrence of the Event of Default (the “Cure Period”), the amount equal to one hundred fifty percent (150%) of the outstanding principal amount of this Note, together with accrued interest and other amounts owing shall become at the holder’s election, immediately due and payable in cash. The holders at its option have the right, with three (3) business days advance written notice to the Company after the expiration of the Cure Period, to elect to convert the Notes into shares of the Company’s common stock pursuant to the Optional Conversion rights disclosed above.
		●	The Company’s Condensed Consolidated Balance Sheets report the following related to the convertible promissory note:				●	The Company’s Condensed Consolidated Balance Sheets report the following related to the convertible promissory note:
			March 3l, 2015					31-Dec-14
	Principal amount		$	213,337		Principal amount		$	213,337
	Unamortized debt discount			(26,178	)	Unamortized debt discount			(34,904	)
	Net carrying amount		$	187,159		Net carrying amount		$	178,433
	The Company valued the warrants as the difference in the value of the Note at its stated interest rate of 12% and the fair value of the Note at its discounted value using an expected borrowing rate of 18%.					The Company valued the warrants as the difference in the value of the Note at its stated interest rate of 12% and the fair value of the Note at its discounted value using an expected borrowing rate of 18%.
	For the period ended March 31, 2015, none of the debt had been converted and no warrants to purchase common stock had been exercised.					For the period ended December 31, 2014, the Company recorded a debt discount of $34,904 associated with the value of the warrants which is being amortized over the life of the notes. At December 31, 2014, none of the debt had been converted and no warrants to purchase common stock had been exercised.
	Under the guidance of ASC 470-20 Debt With Conversion and Other Options, the common shares of the Company, pending being listed on the OTC, and the net settlement requirements of the warrants will be analyzed at the end of each quarter to determine if the conversion does become readily convertible to cash which would require derivative accounting calculations and recording.					Under the guidance of ASC 470-20 Debt With Conversion and Other Options, the common shares of the Company, pending being listed on the OTC, and the net settlement requirements of the warrants will be analyzed at the end of each quarter to determine if the conversion does become readily convertible to cash which would require derivative accounting calculations and recording.

Preferred_and_Common_Stock

Preferred and Common Stock	3 Months Ended					12 Months Ended
	Mar. 31, 2015					Dec. 31, 2014
Equity [Abstract]
Preferred and Common Stock	Note 8. Preferred and Common Stock					Note 9. Preferred and Common Stock
	Preferred Stock					Preferred Stock
	The total number of shares of preferred stock which the Company shall have authority to issue is 10,000,000 shares with a par value of $0.001. There have been no preferred shares issued as of March 31, 2015.					The total number of shares of preferred stock which the Company shall have authority to issue is 10,000,000 shares with a par value of $0.001. There have been no preferred shares issued as of the year ended December 31, 2014.
	Common Stock					Common Stock
	The total number of shares of common stock which the Company shall have authority to issue is 100,000,000 shares with a par value of $0.001.					The total number of shares of common stock which the Company shall have authority to issue is 100,000,000 shares with a par value of $0.001.
	On January 24, 2015, the Company authorized the issuance of 400,000 shares for consulting services at a value of $40,000 that will be amortized over the life of the contract.					As of the year ended December 31, 2014, the Company has 16,421,000 shares of $0.001 par value common stock issued and outstanding.
	On February 23, 2015, the Company authorized the issuance of 60,000 shares for consulting services for a value of $6,000 that will be amortized over the life of the contract.					Holders of shares of common stock are entitled to cast one vote for each share held at all stockholders’ meetings for all purposes including the election of directors. The common stock does not have cumulative voting rights.
	As of the period ended March 31, 2015, the Company has 16,881,000 shares of $0.001 par value common stock issued and outstanding.					No holder of shares of stock of any class is entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.
	Holders of shares of common stock are entitled to cast one vote for each share held at all stockholders’ meetings for all purposes including the election of directors. The common stock does not have cumulative voting rights.
	No holder of shares of stock of any class is entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.
	The Company is currently conducting an offering of up to $1,200,000 convertible secured notes. On December 23, 2014, the Company closed the initial offering (See Footnote 7). During the period ended March 31, 2015, the Company received $146,100 in funds as part of the second part of the original offering. The receipt of these funds was recorded as a short term liability for the period ended March 31, 2015. The second part of the original offering was closed on April 9, 2015 and convertible notes and warrants were issued.
	Warrants
	On January 24, 2015, the Company authorized the issuance of 400,000 warrants that were issued as part of a consulting agreement extension that expired on October 21, 2015. The fair value of the warrants are $32,187 and the Company recorded $7,153 as consulting expense and $25,034 as prepaid expense to be amortized over the life of the contract which expires in October, 2015.
	The following is a summary of the status of all of the Company’s warrants as of March 31, 2015 and changes during the three months ended on that date:
				Weighted
		Number of		Average
		Warrants		Exercise Price
	Outstanding at January 1, 2015		-	$	-
	Granted		400,000	$	0.35
	Exercised		-	$	-
	Cancelled		-	$	-
	Outstanding at March 31, 2015		400,000	$	0.35

Commitments_Contingencies

Commitments, Contingencies	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments, Contingencies	Note 9. Commitments, Contingencies	Note 10. Commitments, Contingencies
	The Company may be subject to lawsuits, administrative proceedings, regulatory reviews or investigations associated with its business and other matters arising in the normal conduct of its business. The following is a description of an uncertainty that is considered other than ordinary, routine and incidental to the business.	The Company may be subject to lawsuits, administrative proceedings, regulatory reviews or investigations associated with its business and other matters arising in the normal conduct of its business. The following is a description of an uncertainty that is considered other than ordinary, routine and incidental to the business.
	The closing of the Initial Exchange Agreement with Private Co. was conditioned upon certain, limited customary representations and warranties, as well as, among other things, our compliance with Rule 419 (“Rule 419”) of Regulation C under the Securities Act of 1933, as amended (the “Securities Act”) and the consent of our shareholders as required under Rule 419. Accordingly, we conducted a “Blank Check” offering subject to Rule 419 (the “Rule 419 Offering”) and filed a Registration Statement on Form S-1 to register the shares of such offering; the Registration Statement was declared effective on September 14, 2012. We used 10% of the subscription proceeds as permitted under Rule 419 and the amount remaining in the escrow trust as of the date of the closing of the Share Exchange was $90,000 (the “Trust Account Balance”).	The closing of the Initial Exchange Agreement with Private Co. was conditioned upon certain, limited customary representations and warranties, as well as, among other things, our compliance with Rule 419 (“Rule 419”) of Regulation C under the Securities Act of 1933, as amended (the “Securities Act”) and the consent of our shareholders as required under Rule 419. Accordingly, we conducted a “Blank Check” offering subject to Rule 419 (the “Rule 419 Offering”) and filed a Registration Statement on Form S-1 to register the shares of such offering; the Registration Statement was declared effective on September 14, 2012. We used 10% of the subscription proceeds as permitted under Rule 419 and the amount remaining in the escrow trust as of the date of the closing of the Share Exchange was $90,000 (the “Trust Account Balance”).
	Rule 419 required that the Share Exchange occur on or before March 18, 2014, but due to normal negotiations regarding the transactions and the parties’ efforts to satisfy all of the closing conditions, the Share Exchange did not close on such date. Accordingly, after numerous discussions with management of both parties, they entered into an Amended and Restated Share Exchange Agreement (the “Share Exchange Agreement”) to reflect a revised business combination structure, pursuant to which we would: (i) file a registration statement on Form 8-A (“Form 8A”) to register our common stock pursuant to Section 12(g) of the Exchange Act, which we did on May 1, 2014 and (ii) seek to convert the participants of the Rule 419 Offering into participants of a similarly termed private offering (the “Converted Offering”), to be conducted pursuant to Regulation D, as promulgated under the Securities Act.	Rule 419 required that the Share Exchange occur on or before March 18, 2014, but due to normal negotiations regarding the transactions and the parties’ efforts to satisfy all of the closing conditions, the Share Exchange did not close on such date. Accordingly, after numerous discussions with management of both parties, they entered into an Amended and Restated Share Exchange Agreement (the “Share Exchange Agreement”) to reflect a revised business combination structure, pursuant to which we would: (i) file a registration statement on Form 8-A (“Form 8A”) to register our common stock pursuant to Section 12(g) of the Exchange Act, which we did on May 1, 2014 and (ii) seek to convert the participants of the Rule 419 Offering into participants of a similarly termed private offering (the “Converted Offering”), to be conducted pursuant to Regulation D, as promulgated under the Securities Act.
	Fifty-two persons participated in the Rule 419 Offering and each of them gave the Company his/her/its consent to use his/her/its escrowed funds to purchase shares of the Company’s restricted common stock in the Converted Offering (the “Consent”) rather than have their funds returned. To avoid further administrative work for the investors, we believe that we took reasonable steps to inform investors of the situation and provided them with an appropriate opportunity to maintain their investment in the Company, if they so choose, or have their funds physically returned. Management believed the steps it took constituted a constructive return of the funds and therefore met the requirements of Rule 419.	Fifty-two persons participated in the Rule 419 Offering and each of them gave the Company his/her/its consent to use his/her/its escrowed funds to purchase shares of the Company’s restricted common stock in the Converted Offering (the “Consent”) rather than have their funds returned. To avoid further administrative work for the investors, we believe that we took reasonable steps to inform investors of the situation and provided them with an appropriate opportunity to maintain their investment in the Company, if they so choose, or have their funds physically returned. Management believed the steps it took constituted a constructive return of the funds and therefore met the requirements of Rule 419.
	However, pursuant to Rule 419(e)(2)(iv), “funds held in the escrow or trust account shall be returned by first class mail or equally prompt means to the purchaser within five business days [if the related acquisition transaction does not occur by a date that is 18 months after the effective date of the related registration statement].” As set forth above, rather than physically return the funds, we sought consent from the investors of the Rule 419 Offering to direct their escrowed funds to the Company to instead purchase shares in the Converted Offering. The consent document (which was essentially a form of rescission) was given to the investors along with a private placement memorandum describing the Converted Offering and stated that any investor who elected not to participate in the Converted Offering would get 90% of their funds physically returned. Pursuant to Rule 419(b)(2)(vi), a blank check company is entitled to use 10% of the proceed/escrowed funds; therefore, if a return of funds is required, only 90% of the proceed/escrowed funds need be returned. The Company received $100,000 proceeds and used $10,000 as per Rule 419(b)(2)(vi); therefore, only $90,000 was subject to possible return.	However, pursuant to Rule 419(e)(2)(iv), “funds held in the escrow or trust account shall be returned by first class mail or equally prompt means to the purchaser within five business days [if the related acquisition transaction does not occur by a date that is 18 months after the effective date of the related registration statement].” As set forth above, rather than physically return the funds, we sought consent from the investors of the Rule 419 Offering to direct their escrowed funds to the Company to instead purchase shares in the Converted Offering. The consent document was given to the investors along with a private placement memorandum describing the Converted Offering and stated that any investor who elected not to participate in the Converted Offering would get 90% of their funds physically returned. Pursuant to Rule 419(b)(2)(vi), a blank check company is entitled to use 10% of the proceed/escrowed funds; therefore, if a return of funds is required, only 90% of the proceed/escrowed funds need be returned. The Company received $100,000 proceeds and used $10,000 as per Rule 419(b)(2)(vi); therefore, only $90,000 was subject to possible return.
	As disclosed therein, we filed the amendments to the initial Form 8-K in response to comments from the SEC regarding the Form 8-K and many of those comments pertain to an alleged violation of Rule 419. The Company continued to provide the SEC with information and analysis as to why it believes it did not violate Rule 419, but was unable to satisfy the SEC’s concerns. Comments and communications indicate that Rule 419 requires a physical return of funds if a 419 offering cannot be completed because a business combination was not consummated within the required time frame; constructive return is not permitted.	As disclosed therein, we filed the amendments to the initial Form 8-K in response to comments from the SEC regarding the Form 8-K and many of those comments pertain to the Company’s potential violation of Rule 419. The Company continued to provide the SEC with information and analysis as to why it believes it did not violate Rule 419, but was unable to satisfy the SEC’s concerns. Comments and communications indicate that Rule 419 requires a physical return of funds if a 419 offering cannot be completed because a business combination was not consummated within the required time frame; constructive return is not permitted.
	As a result of these communications and past comments, we are disclosing that we did not comply with the requirements of Rule 419, which required us to physically return the funds previously submitted to escrow pursuant to the Rule 419 Offering. As a result of our failure to comply with Rule 419, the SEC may bring an enforcement action or commence litigation against us for failure to strictly comply with Rule 419. If any claims or actions were to be brought against us relating to our lack of compliance with Rule 419, we could be subject to penalties (including criminal penalties), required to pay fines, make damages payments or settlement payments. In addition, any claims or actions could force us to expend significant financial resources to defend ourselves, could divert the attention of our management from our core business and could harm our reputation.	As a result of these communications and past comments, we are disclosing that we did not comply with the requirements of Rule 419, which required us to physically return the funds previously submitted to escrow pursuant to the Rule 419 Offering. As a result of our failure to comply with Rule 419, the SEC may bring an enforcement action or commence litigation against us for failure to strictly comply with Rule 419. If any claims or actions were to be brought against us relating to our lack of compliance with Rule 419, we could be subject to penalties (including criminal penalties), required to pay fines, make damages payments or settlement payments. In addition, any claims or actions could force us to expend significant financial resources to defend ourselves, could divert the attention of our management from our core business and could harm our reputation.
	Ultimately, the SEC determined to terminate its review of the Initial Form 8-K and related amendments, rather than provide us with additional opportunities to address their concerns and therefore, we did not clear their comments. It is not possible at this time to predict whether or when the SEC may initiate any proceedings, when this issue may be resolved or what, if any, penalties or other remedies may be imposed, and whether any such penalties or remedies would have a material adverse effect on our consolidated financial position, results of operations, or cash flows. Litigation and enforcement actions are inherently unpredictable, the outcome of any potential lawsuit or action is subject to significant uncertainties and, therefore, determining at this time the likelihood of a loss, any SEC enforcement action and/or the measurement of the amount of any loss is complex. Consequently, we are unable to estimate the range of reasonably possible loss. Our assessment is based on an estimate and assumption that has been deemed reasonable by management, but the assessment process relies heavily on an estimate and assumption that may prove to be incomplete or inaccurate, and unanticipated events and circumstances may occur that might cause us to change that estimate and assumption. In light of the uncertainty of this issue and while Management evaluates the best and most appropriate way to resolve same, management determined to create a reserve on the Company’s Balance Sheet for the $90,000 that was subject to the Consent.	Ultimately, the SEC determined to terminate its review of the Initial Form 8-K and related amendments, rather than provide us with additional opportunities to address their concerns and therefore, we did not clear their comments. It is not possible at this time to predict whether or when the SEC may initiate any proceedings, when this issue may be resolved or what, if any, penalties or other remedies may be imposed, and whether any such penalties or remedies would have a material adverse effect on our consolidated financial position, results of operations, or cash flows. Litigation and enforcement actions are inherently unpredictable, the outcome of any potential lawsuit or action is subject to significant uncertainties and, therefore, determining at this time the likelihood of a loss, any SEC enforcement action and/or the measurement of the amount of any loss is complex. Consequently, we are unable to estimate the range of reasonably possible loss. Our assessment is based on an estimate and assumption that has been deemed reasonable by management, but the assessment process relies heavily on an estimate and assumption that may prove to be incomplete or inaccurate, and unanticipated events and circumstances may occur that might cause us to change that estimate and assumption. In light of the uncertainty of this issue and while Management evaluates the best and most appropriate way to resolve same, management determined to create a reserve on the Company’s Balance Sheet for the $90,000 that was subject to the Consent.
	On or about June 23, 2014, we entered into a license agreement with Bistromatics Corp., to which one of our directors is Chief Marketing Officer, pursuant to which we obtained a perpetual license to use the programming code created by a video management platform as a base to develop our telemedicine video service for a license fee of $20,000 due by September 31, 2014. The parties entered into an addendum extending the due date of the license fee to December 31, 2014. Intellectual property developed as a result of this license, will be our property; but Bistromatics will retain the intellectual property for the original code base. We may resell or license the resulting telemedicine platform for an extended license fee of $10,000 for each additional instance the code base will be used. Through this agreement, Bistromatics Corp. built our PHZIO.com platform; our director purchased the domain name on behalf of the Company and retains no rights to same. On March 16, 2015, the Company extended the licensing fee payment agreement until July 1, 2015. The Company made an initial payment of $5,000 with the remaining fees to be to be paid on or before July 1, 2015.	MHI Agreement: On May 24, 2013, eWellness entered into an exclusive 25-year Supply and Distribution Agreement (the “Agreement”) with Millennium Healthcare, Inc. (“MHI”) for the following 14 states that include: Maine, New Hampshire, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Delaware Maryland, Virginia, North Carolina, South Carolina, Georgia and Florida. Under the agreement, eWellness agrees to provide its eWellness Distance Monitored Physical Therapy Program (“DMpt program”) to MHI affiliated physicians within the terms of the Agreement. MHI agreed to market the eWellness DMpt and agreed to use its best efforts to promote and use the DMpt program; MHI also agreed to assist in managing the insurance reimbursement to eWellness for PT evaluations, re-evaluations and physical tests that eWellness staff perform at selected MHI facilities; however, we will be responsible for seeking reimbursement opportunities from insurance providers who do not currently reimburse for our telemedicine services. MHI, through its wholly owned operating subsidiaries, provide primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices focused primarily on preventive care through early detection. MHI currently provides their services to 70 medical group offices in NYC and approximately 130 in Northern New Jersey. There are approximately 400 individual physicians in these various practices. Approximately 20 percent of those patient visits are reoccurring visits.
	The Company rents its Culver City, CA office space from a company owned by our CEO. The rental agreement provides for the value of the rent of $500 per month be recorded as contributed towards the founding eWellness and its operations. During the period ended March31, 2015, we have recorded this rent payment in the Consolidated Statements of Operations and Additional Paid in Capital on the Balance Sheet.	MHI will charge eWellness a 20% billing fee on all insurance reimbursement or patient fees for marketing the DMpt Program and assisting in the processing of insurance reimbursement. We have also agreed that for every $100,000.00 of insurance reimbursement received from MHI patients for our DMpt program (up to $1 million in billing), we will issue 110,000 shares of our common stock to MHI, up to a maximum amount of 1.1 million shares. As of the date of this Report, we have not issued any shares to MHI under this Agreement because we have not yet required or utilized MHI’s reimbursement services, nor has MHI marketed our services.
	In May 2014, the Company signed an Office Service Agreement for office space in New York, New York. A deposit of $17,874 was paid and recorded in prepaid expense. The utilization of the office space began on August 1, 2014 and terminated at December 31, 2014. The Company negotiated a settlement of $5,500 in April, 2015 for the cancellation of the agreement. The settlement resulted in a gain on extinguishment of debt of $11,323.	Each party has the right to terminate the agreement upon breach of the Agreement or dissolution of either party. We may also terminate the Agreement if MHI is, for a period of 60 continuous days, restrained or prevented from transacting a substantial part of their business by reason of a judgment order or regulation of any court or authority; MHI may terminate the Agreement at any time with 30 days written notice. The parties may also terminate the Agreement if either becomes the subject to any bankruptcy or similar proceeding. The Agreement also includes standard indemnification provisions for both parties.
	On January 24, 2015, the Company received $20,000 in exchange for a 90-day Promissory Note at an interest rate of 12% per annum. For the period ended March 31, 2015, the Company recorded $447 of accrued interest for this note.	Programming Agreement: On or about June 23, 2014, we entered into a license agreement with Bistromatics Corp., to which one of our directors, Curtis Hollister, is Chief Marketing Officer, pursuant to which we obtained a perpetual license to use the programming code created by a video management platform as a base to develop our telemedicine video service for a license fee of $20,000; $2,000 of which was due upon execution, $5,000 of which is due on August 1, 2014 and the $13,000 balance is due by September 15, 2014. The parties entered into an addendum extending the due date of the $20,000 license fee to December 31, 2014 and another addendum extending it to July 1, 2015. Intellectual property developed as a result of this license, will be our property; but Bistromatics will retain the intellectual property for the original code base. We may resell or license the resulting telemedicine platform for an extended license fee of $10,000 for each additional instance the code base will be used. Through this agreement, Bistromatics Corp. built our PHZIO.com platform; Mr. Hollister purchased the domain name on behalf of the Company and retains no rights to same.
	On January 24, 2015 the Company extended a previous consulting and service agreement with a consultant from April 21, 2015 to October 20, 2015 in exchange for 400,000 shares of restricted common stock and 400,000 callable common stock purchase warrants at a strike price of $0.35 per share. The fair value of the common stock issued for the services is $40,000 and the Company recorded $8,889 as consulting expense and $31,111 as prepaid expense to be amortized over the life of the contract. The fair value of the warrants issued for services is $32,187 and the Company recorded $7,153 as consulting expense and $25,034 as prepaid expense to be amortized over the life of the contract. With this extension agreement, the Company is to pay $10,000 per month consulting fee beginning with February 1, 2015 through the end of the agreement. For the period ended March 31, 2015, the Company accrued $20,000 for these consulting fees.	Office Space: The Company rents its Culver City, CA office space from Evolution Physical Therapy (“Evolution”), a company owned by our CEO, Mr. Fogt. Evolution has agreed to cancel and contribute the annual rent for the year ended December 31, 2013 towards founding eWellness and its operations; the market value of such rent is $500 per month. During the period ended December 31, 2014, we have recorded this rent payment in the Consolidated Statements of Operations and Additional Paid in Capital on the Balance Sheet.
	On February 14, 2015, the Company entered into a one-year agreement with BMT, Inc. as a consultant and advisor in connection with certain business development advisory. This agreement is on an at-will basis as determined by the company in exchange for cash compensation to be invoiced monthly. The total compensation paid to date on this agreement is $11,950.
	On February 23, 2015, the Company entered into a one-year agreement with a consultant in connection with certain corporate finance, investor relations and related business matters in exchange for 60,000 shares of restricted common stock. The fair value of the services is $6,000 and the Company recorded $500 as consulting expense and $5,500 as prepaid expense to be amortized over the life of the contract that expires in February, 2016.
	From time to time the Company may become a party to litigation matters involving claims against the Company. Except as may be outlined above, management believes that there are no current matters that would have a material effect on the Company’s financial position or results of operations.

Segment_Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting	Note 10. Segment Reporting
	The Company has one operating segment, which was identified based upon the availability of discrete financial information and the chief operating decision makers’ regular review of financial information.

Subsequent_Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Note 11. Subsequent Events	Note 11. Subsequent Events
	On April 1, 2015, the Company entered into an Operating Agreement with Evolution Physical Therapy (“EPT”), a company owned by one of the Company’s officers, wherein it is agreed that EPT would be able to operate the Company’s telemedicine platform www.phzio.com and offer it to selected physical therapy patients of EPT. The Company is to receive 75% of the net insurance reimbursements from the patient for use of the platform. The Company will advance capital requested by EPT for costs specifically associated with operating the www.phzio,com platform and associated physical therapy treatments – computer equipment, office or facilities rental payments, physical therapist or physical therapy assistant, administrative staff, patient induction equipment, office supplies, utilities and other associated operating costs. It is anticipated that the operation of the platform by EPT will generate positive cash flow within 90 days from the start of patient induction.	On January 24, 2015, the Company received $20,000 in exchange for a 90-day Promissory Note at an interest rate of 12% per annum.
	On April 9, 2015, the Company closed a second round of its private placement offering with eight accredited investors in which it raised gross proceeds of $270,080 (including an aggregate of $123,980 that was converted from certain other outstanding notes, including accrued interest, and future contractual cash consulting fees) and sold that same amount of Series A Senior Convertible Redeemable Notes convertible into shares of the Company’s common stock, par value $0.001 per share at $0.35 per share and Series A Warrants, all pursuant to separate Securities Purchase Agreements entered into with each investor. The Warrants are exercisable to purchase up to 834,857 shares of Common Stock. The sale was part of a private placement offering in which the Company offered for sale a maximum of $1,200,000 principal amount of convertible notes.	On January 24, 2015 the Company extended a previous consulting and service agreement with a consultant from April 21, 2015 to October 20, 2015 for which the Company shall issue 400,000 shares of restricted common stock and 400,000 callable common stock purchase warrants at a strike price of $0.35 per share. As of the date of this report the 400,000 shares have not been issued.
	On April 17, 2015, the Company entered into an agreement with Akash Bajaj, M.D., M.P.H. The agreement is for Dr. Bajaj to serve as a consultant and as the Chairman of the Company’s Clinical Advisory Board. The term of the agreement is for one year with annual renewal as desired. The agreement further sets the hourly rate to be paid at $225 per hour with payment to be at the end of each month. Further, the Company granted Dr. Bajaj a five-year non-statutory option to purchase 100,000 shares of common stock at a price of $.35 per share. The options will vest over a 12 month period at 8,333 per month. As the Company’s stock is not yet publicly traded, the value of the options are deemed to be zero.	On February 14, 2015, the Company entered into a one-year agreement with BMT, Inc. as a consultant and advisor in connection with certain business development advisory. This agreement is on an at-will basis as determined by the company in exchange for cash compensation to be invoiced monthly. The total compensation paid to date on this agreement is $11,950.
	On May 7, 2015, Evolution Physical Therapy inducted the first patient using the Company’s telemedicine platform www.phzio.com.	On February 23, 2015, the Company entered into a one-year agreement with a consultant in connection with certain corporate finance, investor relations and related business matters in exchange for 60,000 shares of restricted common stock. As of the date of this report, the 60,000 shares have not been issued.
		On March 16, 2015, the Company extended a $20,000 licensing fee payment agreement with Bistromatics, Inc. pertaining to intellectual property utilized by the company until July 1, 2015. The Company made an initial payment of $5,000 with the remaining fees to be to be paid on or before July 1, 2015.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation	Basis of Presentation
	The interim financial information of the Company as of periods ended March 31, 2015 and March 31, 2014 is unaudited. The balance sheet as of December 31, 2014 is derived from audited financial statements of eWellness Healthcare Corporation. The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial statements. Accordingly, they omit or condense footnotes and certain other information normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles. The accounting policies followed for quarterly financial reporting conform to the accounting policies disclosed in ASU 2014-10. In the opinion of management, all adjustments which are necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that can be expected for the entire year ending December 31, 2015. The unaudited financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2014.	These financial statements have been prepared to reflect the financial position, results of operations and cash flows of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
Use of Estimates	Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these good faith estimates and judgments.	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from these good faith estimates and judgments.
Going Concern	Going Concern
	For the period ended March 31, 2015, the Company has no revenues and no operations. The Company has an accumulated loss of $2,211,005. In view of these matters, there is substantive doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue operations is dependent upon the Company’s ability to raise additional capital and to ultimately achieve sustainable revenues and profitable operations, of which there can be no guarantee. The Company intends to finance its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.
Deferred Offering and Acquisition Costs	Deferred Offering and Acquisition Costs
	The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs will be charged against the capital raised. Should the offering be terminated, the deferred offering costs will be charged to operations during the period in which the offering is terminated. Direct acquisition costs will be expensed as incurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company complies with the accounting guidance under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820-10, Fair Value Measurements, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.	The Company’s financial instruments consist of cash and accounts payable. The carrying amount of cash and accounts payable approximates fair value because of the short-term nature of these items.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:
	Level 1 – quoted market prices in active markets for identical assets or liabilities.
	Level 2 – inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	As of March 31, 2015 and 2014, the Company did not have Level 1, 2, or 3 financial assets or liabilities.
Cash and Cash Equivalents	Cash and Cash Equivalents	Cash and Cash Equivalents
	Cash and cash equivalents includes all cash deposits and highly liquid financial instruments with an original maturity to the Company of three months or less.	The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.
Property and Equipment	Property and Equipment	Property and Equipment
	Property and equipment consists of assets with useful lives longer than one year. Useful lives for assets have been determined to be 5 years for the Company.	Property and equipment are recorded at historical cost. Minor additions and renewals are expensed in the year incurred. Major additions and renewals are capitalized and depreciated over their estimated useful lives. Depreciation is recorded over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant property and equipment categories are as follows:
		Furniture and Fixtures	5 - 7 Years
		Computer Equipment	5 - 7 Years
		Software	3 Years
		The Company regularly evaluates whether events or circumstances have occurred that indicate the carrying value of long-lived assets may not be recoverable. If factors indicate the asset may not be recoverable, we compare the related undiscounted future net cash flows to the carrying value of the asset to determine if impairment exists. If the expected future net cash flows are less than the carrying value, an impairment charge is recognized based on the fair value of the asset. For the years ended December 31, 2014 and 2013, there was no impairment recognized.
Revenue Recognition	Revenue Recognition
	The Company has yet to realize revenues from operations. Once the Company has commenced operations, it will recognize revenues when delivery of goods or completion of services has occurred provided there is persuasive evidence of an agreement, acceptance has been approved by its customers, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable.
Loss per Common Share	Loss per Common Share	Loss Per Share
	The Company follows ASC Topic 260 to account for the loss per share. Basic loss per common share calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per common share calculations are determined by dividing net loss by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation. As the Company has no common stock equivalents and has incurred losses for the period ended March 31, 2015, no dilutive shares are added into the loss per share calculations.	Basic loss per common share (“EPS”) is calculated by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted EPS is calculated by dividing net income (loss) by the weighted average number of common shares outstanding, plus the assumed exercise of all dilutive securities using the treasury stock or “as converted” method, as appropriate. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements	Recent Pronouncements
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements presentation.	Adoption of ASU 2014-10 Development Stage Entities
		In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein.
		The Company adopted this standard effective June 30, 2014. The Company’s financial statements have been impacted by the adoption of this ASU mainly by the removal of inception-to-date information in the Company’s statements of operations, cash flows, and stockholders’ equity.
		From time to time, new accounting pronouncements are issued by FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption.
Principles of Consolidation		Principles of Consolidation
		The accompanying consolidated financial statements include the accounts of eWellness Healthcare Corporation and its wholly owned subsidiary eWellness Corporation. All significant inter-company balances and transactions have been eliminated in consolidation.
Financial Statement Reclassification		Financial Statement Reclassification
		Certain account balances from prior periods have been reclassified in these audited consolidated financial statements so as to conform to current period classifications.
Intangible Assets		Intangible Assets
		The Company accounts for assets that are not physical in nature as intangible assets. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. Intangible assets with indefinite useful lives are reassessed each year for impairment. If an impairment has occurred, then a loss is recognized. An impairment loss is determined by subtracting the asset’s fair value from the asset’s book/carrying value.
Income Taxes		Income Taxes
		The Company accounts for income taxes under FASB ASC 740-10-30. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accounting standards require the consideration of a valuation allowance for deferred tax assets if it is “more likely than not” that some component or all of the benefits of deferred tax assets will not be realized.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Estimated Useful Lives for Significant Property and Equipment	The estimated useful lives for significant property and equipment categories are as follows:
	Furniture and Fixtures	5 - 7 Years
	Computer Equipment	5 - 7 Years
	Software	3 Years

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Liabilities	Net deferred tax liabilities consist of the following components as of December 31, 2014 and 2013:
		2014			2013
	Deferred tax assets:
	NOL Carryover	$	314,000		$	15,067
	Deferred Rent		2,300			-
	Accrued Payroll		115,200			-
	Contingent Liability		31,500			-
	Deferred tax liabilities
	Depreciation		(300	)		-
	Valuation allowance		(462,700	)		(15,067	)
	Net deferred tax asset	$	-		$	-
Schedule of Pretax From Continuing Operations	The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2014 and 2013 due to the following:
		2014			2013
	Book Income	$	(468,900	)	$	(158,656	)
	Depreciation		(300	)		-
	Contributed Services					143,820
	Non-Deductible Expenses		-			709
	Meals & Entertainment		2,500			-
	Stock for Expense Accounts		21,000			-
	Contributed Interest Expense		900			-
	Gain/Loss on settlement of debt through equity		(400	)		-
	Deferred Rent		-			-
	Accrued Payroll		115,200			-
	Related Party Interest		-			-
	Contingent Liability		31,500			-
	Valuation allowance		298,500			14,127
		$	-		$	-

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	3 Months Ended				12 Months Ended
	Mar. 31, 2015				Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of Convertible Promissory Note		The Company’s Condensed Consolidated Balance Sheets report the following related to the convertible promissory note:				The Company’s Condensed Consolidated Balance Sheets report the following related to the convertible promissory note:
		March 3l, 2015				31-Dec-14
	Principal amount	$	213,337		Principal amount	$	213,337
	Unamortized debt discount		(26,178	)	Unamortized debt discount		(34,904	)
	Net carrying amount	$	187,159		Net carrying amount	$	178,433

Preferred_and_Common_Stock_Tab

Preferred and Common Stock (Tables)	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Summary of Warrant Activity	The following is a summary of the status of all of the Company’s warrants as of March 31, 2015 and changes during the three months ended on that date:
				Weighted
		Number of		Average
		Warrants		Exercise Price
	Outstanding at January 1, 2015		-	$	-
	Granted		400,000	$	0.35
	Exercised		-	$	-
	Cancelled		-	$	-
	Outstanding at March 31, 2015		400,000	$	0.35

The_Company_Details_Narrative

The Company (Details Narrative) (USD $)	0 Months Ended
	Apr. 30, 2014	Apr. 11, 2014	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value			$0.00	$0.00	$0.00
Number of shares of common stock outstanding			15,200,000
Share Exchange Agreement [Member]
Unregistered common stock issued		9,200,000
Common stock, par value		$0.00
Number of common stock returned to company by the officer		5,000,000
Number of shares assigned to shareholders from the holdings of officer		2,500,000
Number of shares owned by the shareholders, total		11,700,000
Additional number of common shares assigned to other parties		2,100,000
Percentage of issued and outstanding common stock own by shareholders of subsidiary	76.97%

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Revenues
Accumulated loss	2,218,158		1,901,279	561,694
Impairment charge recognized

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Estimated Useful Lives for Significant Property and Equipment (Details)	12 Months Ended	3 Months Ended
	Dec. 31, 2014	Mar. 31, 2015
Furniture and Fixtures [Member] | Minimum [Member]
Estimated useful lives	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Estimated useful lives	7 years
Computer Equipment [Member]
Estimated useful lives		5 years
Computer Equipment [Member] | Minimum [Member]
Estimated useful lives	5 years
Computer Equipment [Member] | Maximum [Member]
Estimated useful lives	7 years
Software [Member]
Estimated useful lives	3 years

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Going Concern
Revenues
Accumulated loss	$2,218,158		$1,901,279	$561,694

Property_and_Equipment_Details

Property and Equipment (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Property and equipment	$7,226		$3,231	$4,074
Depreciation expense	211	211	843	140
Computer Equipment [Member]
Property and equipment	8,420		4,214	4,214
Accumulated depreciation	$1,194		$983	$140
Property and equipment useful life	5 years

Intangible_Assets_Details_Narr

Intangible Assets (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Intangible assets	$22,077		$22,816
Amortization expense	739	239
Software License [Member]
Intangible assets	24,770		24,770	0
Accumulated amortization	$2,693		$1,954	$0

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$897,000
Operating loss carryforward loss, expiration dates	2015 through 2034

Income_Taxes_Schedule_of_Defer

Income Taxes - Schedule of Deferred Tax Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
NOL carryover	$314,000	$15,067
Deferred Rent	2,300
Accrued Payroll	115,200
Contingent Liability	31,500
Depreciation	-300
Valuation allowance	-462,700	-15,067
Net deferred tax asset

Income_Taxes_Schedule_of_Preta

Income Taxes - Schedule of Pretax From Continuing Operations (Details) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Book Income			($468,900)	($158,656)
Depreciation			-300
Contributed Services				143,820
Non-Deductible Expenses				709
Meals & Entertainment			2,500
Stock for Expense Accounts			21,000
Contributed Interest Expense			900
Gain/Loss on settlement of debt through equity			-400
Deferred Rent
Accrued Payroll			115,200
Related Party Interest
Contingent Liability			31,500
Valuation allowance			298,500	14,127
Income tax expense benefit		$50

Related_Party_Transactions_10Q

Related Party Transactions (10Q) (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 23, 2014
Accounts Payable-Related Party	$43,056		$56,155	$0
Imputed Interest - related party	1,078		2,708
Percentage of interest rate of related party			8.00%		12.00%
License fee	10,000		10,000
Rent expense	500		500
Accrued expenses - related party	25,076		30,181
Chief Financial Officer [Member]
Amount paid by related parties	73,610		67,710
Chief Marketing Officer [Member]
License fee			20,000
Officer [Member]
Accrued expenses - related party	$25,076		$30,181	$0

Related_Party_Transactions_10K

Related Party Transactions (10K) (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 23, 2014
Accounts Payable-Related Party	$43,056		$56,155	$0
Imputed Interest - related party	1,078		2,708
Percentage of interest rate of related party			8.00%		12.00%
License fee	10,000		10,000
Rent expense	500		500
Accrued expenses - related party	25,076		30,181
Due from officers			7,054	0
Reserch and development expenses		30	30	2,706
Chief Financial Officer [Member]
Amount paid by related parties	73,610		67,710
Chief Marketing Officer [Member]
License fee			20,000
Officer [Member]
Accrued expenses - related party	$25,076		$30,181	$0

Convertible_Notes_Payable_10Q_

Convertible Notes Payable (10Q) (Details Narrative) (USD $)	0 Months Ended	3 Months Ended	0 Months Ended
	Dec. 23, 2014	Mar. 31, 2015	Dec. 23, 2014	Jan. 24, 2015	Dec. 31, 2014
Issuance of convertible promissory notes	$213,337	$213,337	$213,337		$213,337
Interest rate	12.00%		12.00%		8.00%
Principal amount due date	31-Dec-15
Accrued interest	6,969	447	6,969
Redemption right	Redemption right: Any time the closing price of the Company’s common stock has been at or above $1.50 for 20 consecutive trading days, the Company has the right to redeem all or any part of the principal and accrued interest of the Notes, following written notice to the holders of the Notes.
Common stock conversion price per share	$0.35		$0.35
Debt instrument accrued interest rate	150.00%		150.00%	12.00%
Percentage of expected borrowing rate					18.00%
Converted debt
Purchase of warrants exercised
Warrant [Member]
Purchase of additional shares of common stock			$609,534
Purchase of common stock purchase price per share	$0.35		$0.35
Debt instrument accrued interest rate					12.00%

Convertible_Notes_10K_Details_

Convertible Notes (10K) (Details Narrative) (USD $)	0 Months Ended	3 Months Ended		12 Months Ended		0 Months Ended
	Dec. 23, 2014	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 23, 2014	Jan. 24, 2015
Issuance of convertible promissory notes	$213,337	$213,337		$213,337		$213,337
Interest rate	12.00%			8.00%		12.00%
Principal amount due date	31-Dec-15
Redemption right	Redemption right: Any time the closing price of the Company’s common stock has been at or above $1.50 for 20 consecutive trading days, the Company has the right to redeem all or any part of the principal and accrued interest of the Notes, following written notice to the holders of the Notes.
Common stock conversion price per share	$0.35					$0.35
Debt instrument accrued interest rate	150.00%					150.00%	12.00%
Percentage of expected borrowing rate				18.00%
Debt discount		8,726		34,904
Warrant [Member]
Warrants granted right thourgh						31-Dec-15
Purchase of additional shares of common stock						$609,534
Purchase of common stock purchase price per share	$0.35					$0.35
Debt instrument accrued interest rate				12.00%

Convertible_Notes_Payable_Sche

Convertible Notes Payable - Schedule of Convertible Promissory Note (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Dec. 23, 2014	Dec. 31, 2013
Debt Disclosure [Abstract]
Principal amount	$213,337	$213,337	$213,337
Unamortized debt discount	-26,178	-34,904
Net carrying amount	$187,159	$178,433

Preferred_and_Common_Stock_Det

Preferred and Common Stock (Details Narrative) (USD $)	0 Months Ended		3 Months Ended		12 Months Ended
	Feb. 23, 2015	Jan. 24, 2015	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, shares authorized			10,000,000		10,000,000	10,000,000
Preferred stock, par value			$0.00		$0.00	$0.00
Common stock, shares authorized			100,000,000		100,000,000	100,000,000
Common stock, par value			$0.00		$0.00	$0.00
Shares issued during period for consulting services	$6,000	$40,000	($9,389)		($122,100)
Shares issued during period for consulting services, shares	60,000	400,000
Common stock, shares issued			16,881,000		16,421,000	9,200,000
Common stock, shares outstanding			16,881,000		16,421,000	9,200,000
Convertible secured notes			1,200,000
Second part of the original offering			146,100
Prepaid expense			17,874
Warrant [Member]
Authorized issuance warrants were issued			400,000
Fair value of warrants			32,187
Consulting expense			7,153
Prepaid expense			$25,034

Preferred_and_Common_Stock_Sum

Preferred and Common Stock - Summary of Warrant Activity (Details) (Warrant [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Warrant [Member]
Number of Warrants Outstanding, Beginning Balance
Number of Warrants Granted	400,000
Number of Warrants Exercised
Number of Warrants Cancelled
Number of Warrants outstanding, Ending Balance	400,000
Weighted Average Exercise Price, Warrants Outstanding, Beginning Balance
Weighted Average Exercise Price, Warrants Granted	$0.35
Weighted Average Exercise Price, Warrants Exercised
Weighted Average Exercise Price, Warrants Cancelled
Weighted Average Exercise Price, Warrants outstanding, Ending Balance	$0.35

Commitments_Contingencies_10Q_

Commitments, Contingencies (10Q) (Details Narrative) (USD $)	0 Months Ended			1 Months Ended	3 Months Ended		12 Months Ended		0 Months Ended
	Feb. 23, 2015	Jan. 24, 2015	Dec. 23, 2014	Apr. 30, 2015	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Jun. 23, 2014	Feb. 14, 2015
Percentage of returned funds					90.00%		90.00%
Percentage of funds proceed					10.00%		10.00%
Percentage of required funds					90.00%		90.00%
Escrowed funds					$100,000		$100,000
Proceeds from escrowed funds					10,000		10,000
Return of escrowed funds					90,000		90,000
Contingent liability					90,000		90,000
License fee					10,000		10,000
Due date			31-Dec-15
Rent expense					500		500
Prepaid expense					17,874
Negotiated a settlement for cancellation agreement				5,500
Gain on extinguishment of debt					11,323		1,200
Received promissory notes		20,000
Interest rate		12.00%	150.00%
Accured interest			6,969		447
Restricted common stock shares	60,000
Consulting fee					20,000
Shares issued for services	6,000	40,000			-9,389		-122,100
Shares have not issued	60,000
Common Shares [Member]
Shares issued for services							1,221
Warrant [Member]
Prepaid expense					25,034
Interest rate							12.00%
Warrant price per share			$0.35
Consulting Services Agreement [Member]
Prepaid expense	5,500
Consulting fee	500
Shares issued for services	6,000
Consulting Services Agreement [Member] | Common Shares [Member]
Prepaid expense		31,111
Consulting fee		8,889
Shares issued for services		40,000
Consulting Services Agreement [Member] | Warrant [Member]
Prepaid expense		25,034
Consulting fee		7,153
Shares issued for services		32,187
Consulting Services Agreement [Member] | April 20, 2015 To October 20, 2015 [Member]
Restricted common stock shares		400,000
Common stock purchase of warrants		400,000
Warrant price per share		$0.35
Consulting fee		10,000
Shares have not issued		400,000
Escrow Trust [Member]
Percentage of subscription proceeds					10.00%		10.00%
Trust account balance					90,000		90,000
MHI Patients [Member]
Percentage of billing fee					20.00%		20.00%
Reimbursement revenue							100,000
Issues of shares							110,000
Bistromatics Corp., [Member]
License fee					20,000		20,000
Extended license fee					10,000
Balance due							13,000		5,000
Due date					15-Sep-14		15-Sep-14		1-Aug-14
BMT Inc., [Member]
Compensation paid										$11,950

Commitments_Contingencies_10K_

Commitments, Contingencies (10K) (Details Narrative) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended	0 Months Ended
	Dec. 23, 2014	Mar. 31, 2015	Dec. 31, 2014	Jun. 23, 2014	Dec. 31, 2013
Percentage of returned funds		90.00%	90.00%
Percentage of funds proceed		10.00%	10.00%
Percentage of required funds		90.00%	90.00%
Escrowed funds		$100,000	$100,000
Proceeds from escrowed funds		10,000	10,000
Return of escrowed funds		90,000	90,000
Contingent liability		90,000	90,000
License fee		10,000	10,000
Due date	31-Dec-15
Rent expense		500	500
Escrow Trust [Member]
Percentage of subscription proceeds		10.00%	10.00%
Trust account balance		90,000	90,000
MHI Patients [Member]
Percentage of billing fee		20.00%	20.00%
Reimbursement revenue			100,000
Issues of shares			110,000
MHI Patients [Member] | Maximum [Member]
Reimbursement revenue			1,000,000
Issues of shares			1,100,000
Bistromatics Corp., [Member]
License fee		20,000	20,000
Due upon execution			2,000
Balance due			$13,000	$5,000
Due date		15-Sep-14	15-Sep-14	1-Aug-14

Subsequent_Events_10Q_Details_

Subsequent Events (10Q) (Details Narrative) (USD $)	0 Months Ended
	Apr. 09, 2015	Apr. 02, 2015	Apr. 17, 2015	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value				$0.00	$0.00	$0.00
Subsequent Event [Member]
Percentage of receive insurance reimbursements from patient		75.00%
Proceeds from accredited investors	$270,080
Aggregate value of convertible other outstanding notes, accrued interest, future cash consulting fees	123,980
Common stock, par value	$0.00
Price per share	$0.35
Warrants issued for exercisable to purchase common stock	834,857
Convertible notes	1,200,000
Subsequent Event [Member] | Akash Bajaj [Member]
Payment to be paid per hour end of each month			$225
Term of non-statutory option to purchase			5 years
Option to purchase common shares			100,000
Share price			$0.35
Subsequent Event [Member] | Akash Bajaj [Member] | 12 Month [Member]
Stock option vest per month			8,333

Subsequent_Events_10K_Details_

Subsequent Events (10K) (Details Narrative) (USD $)	0 Months Ended		3 Months Ended	12 Months Ended	0 Months Ended
	Feb. 23, 2015	Jan. 24, 2015	Mar. 31, 2015	Dec. 31, 2014	Mar. 16, 2015	Dec. 23, 2014	Feb. 14, 2015
Received promissory notes		$20,000
Interest rate		12.00%				150.00%
Restricted common stock shares	60,000
Shares have not issued	60,000
License fee			10,000	10,000
BMT Inc., [Member]
Compensation paid							11,950
Consulting Services Agreement [Member] | April 20, 2015 To October 20, 2015 [Member]
Restricted common stock shares		400,000
Common stock purchase of warrants		400,000
Warrant price per share		$0.35
Shares have not issued		400,000
Subsequent Event [Member]
Received promissory notes		20,000
Interest rate		12.00%
Restricted common stock shares	60,000
Shares have not issued	60,000
License fee					20,000
Subsequent Event [Member] | July 1, 2015 [Member]
License fee					$5,000
Subsequent Event [Member] | Consulting Services Agreement [Member]
Warrant price per share		$0.35
Shares have not issued		400,000
Subsequent Event [Member] | Consulting Services Agreement [Member] | April 20, 2015 To October 20, 2015 [Member]
Restricted common stock shares				400,000
Common stock purchase of warrants				400,000